Top 10 Things You Need to Know in the New Era of Long-Acting HIV Prevention

Program Overview

Long-acting injectable (LAI) preexposure prophylaxis (PrEP) is reshaping the HIV prevention landscape by offering new opportunities to address persistent barriers related to stigma, patient preferences, and continuity of care. As new LAI PrEP options have emerged and patient awareness of these new agents expands, clinicians must be prepared to identify appropriate candidates, incorporate new clinical protocols, and implement effective workflows for delivery and follow-up. However, many providers remain uncertain about practical considerations related to dosing, laboratory monitoring, injection techniques, missed doses, and patient support and reimbursement strategies in real-world practice.

Led by HIV prevention expert David Wohl, this interactive “Top 10” CME activity is designed to provide concise, evidence-based, and clinically actionable guidance on the most important questions surrounding LAI PrEP implementation to support patient-centered clinical care.

Target Audience

This activity is designed to educate US- and EU-based primary care providers (PCPs), nurse practitioners (NPs) and physician associates (PAs), pediatricians, OB/GYNs, infectious disease specialists, HIV specialists, and sexual health clinicians who provide PrEP.

Educational Objectives 

After completing this activity, the participant should be better able to:

• Describe protocols for LAI PrEP initiation, monitoring, and follow-up
• Select LAI PrEP regimens based on patient preferences and characteristics to support continuity of care
• Determine clinical practice strategies to streamline provision of LAI PrEP

Physician Accreditation Statement

Integritas Communications is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physician Credit Designation

Integritas designates this enduring activity for a maximum of 0.75 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ANCC Reciprocity Statement

The ANCC’s Commission on Accreditation recognizes educational activities that are approved for AMA PRA Category 1 Credits™ by providers who are accredited by the ACCME to award credit to learners. This reciprocity agreement allows nurses and nurse practitioners to use AMA PRA Category 1 Credits™ as approved ANCC contact hours for license renewal. 

Pharmacist Accreditation Statement

Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.

Credit Designation

Global Education Group designates this continuing education activity for 0.75 contact hour(s) (0.075 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Activity Number - 0530-9999-26-018-H02-P)

This is a knowledge-based activity.

Integritas Contact Information

For more information about the accreditation (ACCME credit) of this program, please contact Integritas at info@exchangecme.com. 

Global Contact Information

For information about the accreditation (ACPE credit) of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.

Instructions to Receive Credit

In order to receive credit for this activity, the participant must:

1. Read the educational objectives, accreditation information, and faculty disclosures at the beginning of this activity.
2. Complete the Preactivity Questions.
3. Review the activity content.
4. Achieve a grade of at least 70% on the Postactivity Test Questions and complete the Evaluation.
5. Pharmacists must check the CPE Monitor for credits within 60 days of the activity. Credit for pharmacists cannot be issued after 60 days.

Fee Information & Refund/Cancellation Policy

There is no fee for this educational activity.

Disclosures of Conflicts of Interest

Integritas Communications and Global adhere to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global.  All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.  

All relevant financial relationships have been mitigated. 

The faculty have the following relevant financial relationships with ineligible companies:

David A. Wohl, MD:

• Consulting Fees: Gilead Sciences, Merck & Co, Theratechnologies, and ViiV Healthcare
• Contracted Research: Merck & Co

The planners and managers at Integritas Communications and Global have no relevant financial relationships to disclose. 

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global and Integritas Communications do not recommend the use of any agent outside of the labeled indications.  

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

System Requirement

PC

1.4 GHz Intel Pentium 4 or faster processor (or equivalent)

Windows 10, 8.1 (32-bit/64-bit), Windows 7 (32-bit/64-bit)

512 MB of RAM (1 GB recommended)

Microsoft Internet Explorer 11 or later, Windows Edge browser, Mozilla Firefox, and Google Chrome

For HTML Client – Google Chrome (v70.0 & above), Mozilla Firefox (v65.0 & above), and Edge (v42.0 & above) 

MAC 

1.83 GHz Intel Core Duo or faster processor

512 MB of RAM (1 GB recommended)

MAC OS X 10.12, 10.13 and 10.14

Mozilla Firefox, Apple Safari, Google Chrome

For HTML Client – Google Chrome (v70.0 & above), Apple Safari (v12.0 & above), and Mozilla Firefox (v65.0 & above)